Protocol Ledger

NCT06859424 · Phase II · RECRUITING

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell T

Interventional Phase II clinical trial protocol NCT06859424 sponsored by Center for International Blood and Marrow Transplant Research in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-07-25 Enrollment: 358 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06859424
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)358 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06859424
Protocol FieldVerified Registry Value
NCT IdentifierNCT06859424
Consolidated Lead SponsorCenter for International Blood and Marrow Transplant Research
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment358 participants (ESTIMATED)
Registered Start Date2025-07-25
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI